✦ LIBER ✦

Influence of the CYP2D6 polymorphism and hemodialysis on codeine disposition in patients with end-stage renal disease

✍ Scribed by Hadi Molanaei; Juan Jesus Carrero; Olof Heimbürger; Louise Nordfors; Bengt Lindholm; Peter Stenvinkel; Ingegerd Odar-Cederlöf; Leif Bertilsson

Publisher: Springer
Year: 2009
Tongue: English
Weight: 174 KB
Volume: 66
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-009-0759-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute effects of hemodialysis on lung fu

Acute effects of hemodialysis on lung function in patients with end-stage renal disease

✍ Susanne M. Lang; Anja Becker; Rainald Fischer; Rudolf M. Huber; Helmut Schiffl 📂 Article 📅 2006 🏛 Springer Vienna 🌐 English ⚖ 70 KB

Effect of smoking and CYP2D6 polymorphis

Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine–alprazolam interaction in patients with psychosomatic disease

✍ Hideyo Sugahara; Chiharu Maebara; Hisakazu Ohtani; Masanori Handa; Katsumi Ando; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 146 KB

The effect of haemodialysis on the pharm

The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease

✍ M. S. Al-Ghamdi; F. A. Al-Mohanna; Z. H. Al-Mustafa; I. S. Al-Saeed 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 332 KB

The disposition of paracetamol and its c

The disposition of paracetamol and its conjugates during multiple dosing in patients with end-stage renal failure maintained on haemodialysis

✍ U. Martin; R. M. Temple; R. J. Winney; L. F. Prescott 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 578 KB

The disposition of oral paracetamol (1.0 g 3 times daily for 10 days) was studied in 6 patients with end-stage renal failure (creatinine clearance < 5 ml x min-1) maintained on haemodialysis 2 or 3 times per week. Blood was sampled daily for 10 days. The time of sampling depended on whether the pati

Doppler ultrasound evaluation of morphol

Doppler ultrasound evaluation of morphological and hemodynamical changes of hepatic and mesenteric structures in end-stage renal disease patients on regular hemodialysis

✍ Tarkan Ergun; Hatice Lakadamyali 📂 Article 📅 2009 🏛 Springer Netherlands 🌐 English ⚖ 257 KB

Ischemia-Modified albumin levels in pati

Ischemia-Modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted Ischemia-Modified albumin levels?

✍ Aysel Kıyıcı; İdris Mehmetoğlu; Hatice Karaoğlan; Hüseyin Atalay; Yalçın Solak; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract Ischemia‐Modified albumin (IMA) has been used as an early marker in the evaluation of the patients with acute coronary syndrome. We aimed to evaluate IMA in end‐stage renal disease (ESRD) patients on hemodialysis and the effect of albumin methods on albumin‐adjusted IMA levels. A total